Sector
HealthcareOpen
₹666Prev. Close
₹661.5Turnover(Lac.)
₹26,991.18Day's High
₹669.65Day's Low
₹64352 Week's High
₹744.552 Week's Low
₹375.05Book Value
₹121.77Face Value
₹10Mkt Cap (₹ Cr.)
48,970.36P/E
247.17EPS
2.67Divi. Yield
0.152 Jul 2024
12:00 AM
AGM
Announcement Date: 02 Jul, 2024
23 May 2024
12:00 AM
Dividend
Dividend Amount: 1
Record Date: 24 Jul, 2024
29 Jan 2025
12:00 AM
Board Meeting
Agenda : Audited Result
EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.
The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.
Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.
Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 754.96 | 754.96 | 754.96 | 754.96 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 8,332.21 | 8,208.58 | 8,113.61 | 8,126.57 |
Net Worth | 9,087.17 | 8,963.54 | 8,868.57 | 8,881.53 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 862.61 | 632.87 | 701.84 | 659.48 |
yoy growth (%) | 36.3 | -9.82 | 6.42 | 2.22 |
Raw materials | -204.28 | -150.57 | -147.47 | -135.56 |
As % of sales | 23.68 | 23.79 | 21.01 | 20.55 |
Employee costs | -154.23 | -147.65 | -155.44 | -161.34 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 7.29 | -32.32 | 749.3 | 7.65 |
Depreciation | -112.62 | -110.77 | -96.81 | -28.87 |
Tax paid | -4.26 | -19.93 | -107.34 | -3.42 |
Working capital | -20.9 | 48.61 | -143.94 | 70.63 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 36.3 | -9.82 | 6.42 | 2.22 |
Op profit growth | 313.5 | -58.92 | -280.58 | -74.32 |
EBIT growth | 25.43 | -88 | 1,173.9 | -1,909.32 |
Net profit growth | -415.67 | -99.18 | -905.62 | -14.69 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 6,892.92 | 6,297.63 | 5,717.61 | 4,030.12 | 4,632.32 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 6,892.92 | 6,297.63 | 5,717.61 | 4,030.12 | 4,632.32 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 63.78 | 157.17 | 366.52 | 95.33 | 126.63 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Max Healthcare Institute Ltd MAXHEALTH | 999.9 | 118.99 | 97,165.6 | 138.24 | 0.15 | 697.4 | 81.72 |
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 6,274.1 | 75.15 | 90,307.55 | 341.6 | 0.25 | 2,054.8 | 569.62 |
Fortis Healthcare Ltd FORTIS | 648.65 | 242.3 | 48,842.02 | 39.56 | 0.15 | 366.87 | 120.23 |
Global Health Ltd MEDANTA | 1,252.95 | 85.72 | 33,635.2 | 99.31 | 0 | 624.4 | 113.49 |
Narayana Hrudayalaya Ltd NH | 1,579.2 | 75.1 | 32,230.76 | 79.22 | 0.25 | 865.04 | 95.32 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Independent Director
Suvalaxmi Chakraborty
Director
Indrajit Banerjee
Managing Director & CEO
Ashutosh Raghuvanshi
Independent Director
Shailaja Chandra
Non Executive Director
DILIP KADAMBI
Non Executive Director
Tomo Nagahiro
Non Executive Director
Mehmet Ali Aydinlar
Non Executive Director
Lim Tsin Lin
Company Sec. & Compli. Officer
Satyendra Chauhan
Non Executive Director
Prem Kumar Nair
Non Executive Director
Ashok Pandit
Chairman & Additional Director
Leo Puri
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Fortis Healthcare Ltd
Summary
Fortis Healthcare Limited (FHL) is one of the largest healthcare services providers in India with 27 hospitals, ~4,500 operational beds and over 426 diagnostics centres as of 31 March, 2023. The Company offers a full spectrum of integrated healthcare services ranging from clinics to quaternary care facilities and a wide range of ancillary services to patients in areas such as cardiac care, orthopedics, neurosciences, oncology, renal care, gastroenterology and mother and child care. They are delivering quality healthcare services to patients in modern facilities using advanced technology. It also has presence in Dubai, Mauritius and Sri Lanka.SRL Limited, a subsidiary of FHL is primarily involved in providing diagnostics services and is amongst the leading diagnostics chains in India with a significant market share in the organized diagnostics segment. FHL currently owns a fully diluted stake of 56.6% in SRL.Fortis Healthcare Ltd was incorporated on February 28, 1996. The company commenced their commercial operation by setting up the Fortis Heart Institute and Multi-Speciality Hospital at Mohali in the year 2001. In December 2002, International Hospital Ltd became a board controlled subsidiary of the company.In August 2003, Fortis Hospital in Amristar was inaugurated. In October 2003, the company executed an agreement with Seth Jessa Ram and Bros Charitable Hospital Trust for the operation and management of Jessa Ram Hospital, New Delhi and Fortis Hospital in Noida was commiss
Read More
What is the Fortis Healthcare Ltd share price today?
The Fortis Healthcare Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹648.65 today.
What is the Market Cap of Fortis Healthcare Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Fortis Healthcare Ltd is ₹48970.36 Cr. as of 06 Mar ‘25
What is the PE and PB ratio of Fortis Healthcare Ltd?
The PE and PB ratios of Fortis Healthcare Ltd is 247.17 and 5.49 as of 06 Mar ‘25
What is the 52 Week High and Low of Fortis Healthcare Ltd?
The 52-week high/low is the highest and lowest price at which a Fortis Healthcare Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Fortis Healthcare Ltd is ₹375.05 and ₹744.5 as of 06 Mar ‘25
What is the CAGR of Fortis Healthcare Ltd?
Fortis Healthcare Ltd's CAGR for 5 Years at 34.15%, 3 Years at 36.23%, 1 Year at 70.34%, 6 Month at 18.63%, 3 Month at -9.18% and 1 Month at -0.38%.
What is the shareholding pattern of Fortis Healthcare Ltd?
The shareholding pattern of Fortis Healthcare Ltd is as follows:
Promoters - 31.17 %
Institutions - 56.82 %
Public - 12.01 %
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
